相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
Mark J. Truty et al.
ANNALS OF SURGERY (2021)
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
Max M. Wattenberg et al.
BRITISH JOURNAL OF CANCER (2020)
Outcomes of pancreatic adenocarcinoma that was not resected because of isolated para-aortic lymph node involvement
U. Marchese et al.
JOURNAL OF VISCERAL SURGERY (2019)
Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma
Wei Jiang et al.
ACTA ONCOLOGICA (2019)
International Study Group of Pancreatic Surgery type 3 and 4 venous resections in patients with pancreatic adenocarcinoma:the Paoli-Calmettes Institute experience
Abdallah Al Farai et al.
EJSO (2019)
Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results
Marsha Reyngold et al.
RADIATION ONCOLOGY (2019)
Effect of clinical status on survival in patients with borderline or locally advanced pancreatic adenocarcinoma
Pauline Duconseil et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis
Taiane F. Rebelatto et al.
CANCER TREATMENT REVIEWS (2019)
The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy
Byung Min Lee et al.
GUT AND LIVER (2018)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study
Anne-Marie Marion-Audibert et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
FOLFIRINOX until progression, FOLFIRINOX with maintenance treatment, or sequential treatment with gemcitabine and FOLFIRI.3 for first-line treatment of metastatic pancreatic cancer: A randomized phase II trial (PRODIGE 35-PANOPTIMOX).
Laetitia Dahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Application of Cell-free DNA Analysis to Cancer Treatment
Ryan B. Corcoran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status Results of the Prospective CLUSTER Study
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2018)
Cancer DNA in the Circulation The Liquid Biopsy
Hatim Husain et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Pancreatic Adenocarcinoma, Version 2.2017
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
Matthew H. G. Katz et al.
BMC CANCER (2017)
Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy
J. M. Wilson et al.
CLINICAL ONCOLOGY (2017)
Locally Advanced Pancreatic Cancer Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients
Thilo Hackert et al.
ANNALS OF SURGERY (2016)
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial
Pascal Hammel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer
Paula Ghaneh et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Para-aortic lymph node sampling in pancreatic head adenocarcinoma
L. Schwarz et al.
BRITISH JOURNAL OF SURGERY (2014)
Pancreatic Adenocarcinoma: Treating a Systemic Disease With Systemic Therapy
Davendra P. S. Sohal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension
Philippe Bachellier et al.
SURGERY (2014)
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Pathologic Response to Preoperative Chemoradiation Therapy in Patients With Resectable T3 Pancreatic Cancer
Hirotada Kittaka et al.
WORLD JOURNAL OF SURGERY (2013)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival
Louise Barbier et al.
HPB (2011)
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Neoadjuvant 5 Fluorouracil-Cisplatin Chemoradiation Effect on Survival in Patients with Resectable Pancreatic Head Adenocarcinoma: A Ten-Year Single Institution Experience
Olivier Turrini et al.
ONCOLOGY (2009)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma
V Moutardier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
分享论文
